Results
|
|
1.
|
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology). MedStar authors:
Year: 2017
Citation: - Journal of Clinical Oncology. 35(23):2647-2655, 2017 Aug 10.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Randomized Controlled Trial
All authors: - Asmar L, Blum JL, Brufsky AM, Colangelo LH, Dang CT, Fehrenbacher L, Flynn PJ, Geyer CE Jr, Gomez HL, Hopkins JO, Jacobs SA, Jeong JH, Jones SE, Lyss AP, Mamounas EP, O'Shaughnessy JA, Paul D, Robert NJ, Swain SM, Vukelja SJ, Wolmark N, Yothers G
|
|
|
2.
|
|
|
|
3.
|
Incidence and severity of anaphylaxis and hypersensitivity in trials of intravenous pertuzumab plus trastuzumab or the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection for HER2-positive breast cancer. MedStar authors:
Year: 2022
Citation: - European Journal of Cancer. 178:70-81, 2022 Oct 07.
Medline publication type:
All authors: - Aguila C, Dang CT, Gianni L, Heeson S, Kuemmel S, Liu H, Loibl S, Macharia H, O'Shaughnessy J, Restuccia E, Schneeweiss A, Swain SM, Tan AR, Yang K
|
|
|
4.
|
BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer. MedStar authors:
Year: 2022
Citation: - Cancers. 14(11), 2022 May 24.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Colomer R, Dadswell K, Dang C, de Haas SL, de la Cruz-Merino L, Delaloge S, Eiger D, Ewer MS, Ferrero JM, Restuccia E, Sarkar S, Swain SM, Verrill M, Werner TL
|
|
|
5.
|
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology). MedStar authors:
Year: 2022
Citation: - Breast Cancer Research & Treatment. 193(3):565, 2022 Jun.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Baez-Diaz L, Bandos H, Brufsky AM, Carolla RL, Fehrenbacher L, Geyer CE Jr, Hamm JT, Jacobs SA, Julian TB, Mamounas EP, Paterson AHG, Polikoff J, Provencher L, Rastogi P, Robidoux A, Swain SM, Ward PJ, Wolmark N
|
|
|
6.
|
Best-worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy. MedStar authors:
- Smith, D Max
- Swain, Sandra M
Year: 2022
Citation: - Implementation Science Communications. 3(1):52, 2022 May 14.
Department:
- Associate Dean for Research Development
- MedStar Health
- Pharmacogenomics
Medline publication type:
All authors: - Aquilante CL, Bates J, Beitelshees AL, Bishop JR, Blake KV, Cavallari LH, Cipriani A, Duong BQ, Elchynski AL, Empey PE, Formea CM, Hicks JK, Limdi NA, Mroz P, Oslin D, Pasternak AL, Petry N, Ramsey LB, Rowe E, Salloum RG, Schlichte A, Skaar TC, Smith DM, Swain SM, Tuteja S, Van Driest SL, Ward KM, Wiisanen K
|
|
|
7.
|
Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and management. [Review] MedStar authors:
Year: 2022
Citation: - Cancer Treatment Reviews. 106:102378, 2022 May.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Andre F, Bartholmai BJ, Conte P, Kato T, Lancaster LH, Li BT, Naidoo J, Nicholson AG, Nishino M, Powell CA, Schumacher-Wulf E, Shitara K, Swain SM, Tsurutani J
|
|
|
8.
|
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology). MedStar authors:
Year: 2022
Citation: - Breast Cancer Research & Treatment. 2022 Mar 01
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Baez-Diaz L, Bandos H, Brufsky AM, Carolla RL, Fehrenbacher L, Geyer CE Jr, Hamm JT, Jacobs SA, Julian TB, Mamounas EP, Paterson AHG, Polikoff J, Provencher L, Rastogi P, Robidoux A, Swain SM, Ward PJ, Wolmark N
|
|
|
9.
|
Reply to a. Avan et Al. MedStar authors:
Year: 2015
Citation: - Journal of Clinical Oncology. 33(15):1712, 2015 May 20.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Baselga J, Clark E, Kiermaier A, Swain S
|
|
|
10.
|
A pilot study of a culturally targeted video intervention to increase participation of African American patients in cancer clinical trials. MedStar authors:
- Banda, Deliya R
- Libin, Alexander V
- Swain, Sandra M
- Wang, Hong
Year: 2012
Citation: - Oncologist. 17(5):708-14, 2012.
Institution:
- MedStar Health Research Institute
- MedStar National Rehabilitation Network
- Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Banda DR, Libin AV, Swain SM, Wang H
|
|
|
11.
|
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. MedStar authors:
Year: 2013
Citation: - Lancet Oncology. 14(6):461-71, 2013 May.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, Cortes J, Ferrero JM, Kim SB, Knott A, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM
|
|
|
12.
|
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. MedStar authors:
Year: 2012
Citation: - Lancet. 379(9814):432-44, 2012 Feb 4.
Institution: - Washington Cancer Institute
Medline publication type:
- Comparative Study
- Journal Article
- Meta-Analysis
- Research Support, Non-U.S. Gov't
All authors: - Albain K, Bergh J, Clarke M, Cutter D, Darby S, Davies C, Di Leo A, Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Godwin J, Gray R, McGale P, Pan HC, Peto R, Piccart M, Pritchard K, Swain S, Taylor C, Wang YC
|
|
|
13.
|
Twenty-five year results of the national cancer institute randomized breast conservation trial. MedStar authors:
Year: 2012
Citation: - Breast Cancer Research & Treatment. 132(1):197-203, 2012 Feb.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Camphausen K, Dan T, Danforth DN, Glatstein E, Lippman ME, Lita E, Sciuto L, Shih J, Simone NL, Smith SL, Swain SM
|
|
|
14.
|
Pazopanib for the treatment of breast cancer. [Review] MedStar authors:
Year: 2012
Citation: - Expert Opinion on Investigational Drugs. 21(2):217-25, 2012 Feb.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Review
All authors: - Amiri-Kordestani L, Swain SM, Tan AR
|
|
|
15.
|
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. MedStar authors:
Year: 2012
Citation: - Journal of Clinical Oncology. 30(12):1268-73, 2012 Apr 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Comparative Study
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Allred DC, Anderson SJ, Costantino JP, Geyer CE Jr, Julian TB, Land SR, Mamounas EP, Nagtegaal ID, Paik S, Swain SM, Wickerham DL, Wolmark N
|
|
|
16.
|
Bevacizumab added to neoadjuvant chemotherapy for breast cancer. MedStar authors:
Year: 2012
Citation: - New England Journal of Medicine. 366(4):310-20, 2012 Jan 26.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
All authors: - Adams PT, Atkins JN, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Mamounas EP, Margolese RG, Mehta RS, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA
|
|
|
17.
|
Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer. MedStar authors:
Year: 2012
Citation: - Clinical Breast Cancer. 12(4):232-9, 2012 Aug.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Intramural
- Research Support, U.S. Gov't, Non-P.H.S.
All authors: - Duong QN, Hewitt SM, Hoffman HJ, Levine PH, Portera CC, Swain SM, Takikita M, Yang SX
|
|
|
18.
|
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial. MedStar authors:
Year: 2012
Citation: - Lancet Oncology. 13(7):734-42, 2012 Jul.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Anderson SJ, Baez-Diaz L, Brufsky AM, Costantino JP, Dakhil S, Falkson CI, Fehrenbacher L, Geyer CE Jr, Gralow JR, King KM, Lad T, Lembersky BC, Mamounas EP, Paterson AH, Perez EA, Robidoux A, Swain SM, Weir LM, Wolmark N, Zheng P
|
|
|
19.
|
|
|
|
20.
|
Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia. MedStar authors:
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Alexander LM, Brem R, Caicedo L, Eng-Wong J, Frederick W, Funderburk W, Hoffman HJ, Huerta E, LaVerda NL, Levine PH, Patierno SR, Swain S, Young HA
|
|
|
21.
|
Drug discount program. MedStar authors:
Year: 2013
Citation: - JAMA. 310(15):1626-7, 2013 Oct 16.
Institution: - Washington Cancer Institute
Medline publication type:
|
|
|
22.
|
|
|
|
23.
|
|
|
|
24.
|
Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase III study. MedStar authors:
Year: 2013
Citation: - Oncologist. 18(3):257-64, 2013.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Amadori D, Baselga J, Benyunes MC, Clark E, Cortes J, Ewer MS, Knott A, Miles D, Ross G, Swain SM
|
|
|
25.
|
|
|
|
26.
|
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31. MedStar authors:
Year: 2013
Citation: - Journal of the National Cancer Institute. 105(23):1782-8, 2013 Dec 4.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Bandos H, Blackmon NL, Bohn OL, Burandt E, Costantino JP, Fehrenbacher L, Fumagalli D, Gavin PG, Geyer CE Jr, Goldstein LC, Horne ZD, Jeong JH, Kim C, Kim SI, Kim SR, Lee A, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Reilly ML, Remillard MY, Romond EH, Sneige N, Swain SM, Tanaka N, Taniyama Y, Wickerham DL, Wolmark N
|
|
|
27.
|
|
|
|
28.
|
Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies. MedStar authors:
Year: 2013
Citation: - Clinical Cancer Research. 19(13):3681-92, 2013 Jul 1.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Bais C, Brauer MJ, Chen D, Cheng JH, Chung AS, Clermont AC, Ferrara N, Haley B, Hegde P, James CD, Jubb A, Jurinka SS, Kaminker JS, Koeppen H, Kolumam G, Modrusan Z, Ozawa T, Phillips H, Scherer SJ, Schmidt M, Singh M, Stephan JP, Swain SM, Tam RN, Wu X, Yang SX, Yao J, Yeh RF, Yue P, Zhuang G
|
|
|
29.
|
|
|
|
30.
|
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. MedStar authors:
Year: 2013
Citation: - Lancet Oncology. 14(12):1183-92, 2013 Nov.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Atkins JN, Azar CA, Baez-Diaz L, Bandos H, Bear HD, Brufsky AM, Costantino JP, Farrar WB, Fehrenbacher L, Geyer CE Jr, Mamounas EP, Margolese RG, Paik S, Rastogi P, Robidoux A, Sarwar S, Shibata HR, Swain SM, Tang G, Wolmark N
|
|
|
31.
|
Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial. MedStar authors:
Year: 2013
Citation: - Journal of Clinical Oncology. 31(26):3197-204, 2013 Sep 10.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Atkins JN, Azar CA, Biggs DD, Brufsky AM, Costantino JP, Donnellan PP, Fehrenbacher L, Geyer CE Jr, Levine EA, Mamounas EP, Northfelt DW, Paik S, Polikoff JA, Provencher L, Rastogi P, Robidoux A, Swain SM, Tang G, Wolmark N, Zapas JL
|
|
|
32.
|
Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia. MedStar authors:
Year: 2013
Citation: - Cancer Medicine. 2(2):178-84, 2013 Apr.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Intramural
All authors: - Ayed FB, Ayoub WB, Brown LM, Eissa S, Gail M, Kantor ED, Khalafallah S, Khaled H, Merajver S, Omar S, Schairer C, Soliman AS, Swain SM
|
|
|
33.
|
Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA). MedStar authors:
Year: 2013
Citation: - Breast Cancer Research & Treatment. 142(1):89-99, 2013 Nov.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Amadori D, Baselga J, Clark E, Knott A, Miles D, Ross G, Semiglazov V, Sunpaweravong P, Swain SM
|
|
|
34.
|
Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. MedStar authors:
Year: 2013
Citation: - Annals of Oncology. 24(10):2630-5, 2013 Oct.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Clark E, Cortes J, Im SA, Im YH, Knott A, Pivot X, Ross G, Swain SM
|
|
|
35.
|
Reply to E.J. Moylan et al. MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(6):606-7, 2014 Feb 20.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Geyer CE Jr, Swain SM, Tang G
|
|
|
36.
|
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. [Review] MedStar authors:
Year: 2014
Citation: - Lancet. 384(9938):164-72, 2014 Jul 12.
Medline publication type:
- Journal Article
- Meta-Analysis
- Research Support, U.S. Gov't, P.H.S.
- Review
All authors: - Baselga J, Bergh J, Blohmer J, Blumenthal G, Bogaerts J, Bonnefoi H, Cameron D, Cortazar P, Costantino JP, Ditsch N, Eidtmann H, Eiermann W, Fasching PA, Gerber B, Geyer CE Jr, Gianni L, Justice R, Loibl S, Mamounas EP, Mehta K, Paik S, Pazdur R, Perou C, Piccart M, Prowell T, Rastogi P, Semiglazov V, Slaets L, Sridhara R, Swain SM, Tang S, Untch M, Valagussa P, von Minckwitz G, Wickerham DL, Wolmark N, Zhang L
|
|
|
37.
|
Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer. MedStar authors:
Year: 2014
Citation: - Cancer. 120(17):2657-64, 2014 Sep 1.
Institution: - Washington Cancer Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Observational Study
- Research Support, Non-U.S. Gov't
All authors: - Bloom KJ, Brammer MG, Burris H, Chau M, Gralow JR, Kaufman PA, Lalla D, Mayer M, Pegram M, Rugo HS, Swain SM, Vogel CL, Yardley DA, Yoo B
|
|
|
38.
|
Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel. MedStar authors:
Year: 2013
Citation: - Anti-Cancer Drugs. 24(10):1084-92, 2013 Nov.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Brewster M, Cortes J, Garg A, Grincuka E, Hauschild M, Kudaba I, Lum BL, Marier JF, Masuda N, McNally V, Nijem I, Patel T, Ross G, Swain SM, Trinh MM, Visich J
|
|
|
39.
|
Building bridges to conquer cancer. MedStar authors:
Year: 2013
Citation: - Journal of Clinical Oncology. 31(30):3731-6, 2013 Oct 20.
Institution: - Washington Cancer Institute
Medline publication type:
|
|
|
40.
|
Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer. MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(33):3753-61, 2014 Nov 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Clark E, Cortes J, Im SA, Kiermaier A, Ross G, Swain SM
|
|
|
41.
|
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA. MedStar authors:
Year: 2014
Citation: - Annals of Oncology. 25(6):1116-21, 2014 Jun.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Cortes J, Im YH, Lee LF, Miles D, Quah C, Swain SM
|
|
|
42.
|
Pertuzumab for the treatment of breast cancer. [Review] MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Year: 2014
Citation: - Cancer Investigation. 32(8):430-8, 2014 Oct.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
- Review
|
|
|
43.
|
The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. MedStar authors:
Year: 2014
Citation: - BMC Cancer. 14:307, 2014.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Beattie M, Hurvitz S, Jahanzeb M, Kaufman PA, Lai C, Masaquel A, Mason G, O'Shaughnessy J, Rugo HS, Swain S, Tripathy D, Yoo B
|
|
|
44.
|
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. MedStar authors:
Year: 2015
Citation: - New England Journal of Medicine. 372(8):724-34, 2015 Feb 19.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, CLEOPATRA Study Group, Cortes J, Ferrero JM, Heeson S, Kim SB, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM
|
|
|
45.
|
Treatment of HER2-positive metastatic breast cancer. MedStar authors:
Year: 2015
Citation: - New England Journal of Medicine. 372(20):1964-5, 2015 May 14.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Baselga J, Clark E, Swain SM
|
|
|
46.
|
|
|
|
47.
|
Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial. MedStar authors:
Year: 2015
Citation: - Journal of Clinical Oncology. 33(12):1340-7, 2015 Apr 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Blackmon NL, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Kim SR, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N
|
|
|
48.
|
Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study. [] MedStar authors:
Year: 2015
Citation: - Breast Cancer Research & Treatment. 149(1):163-9, 2015 Jan.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Bhatt K, Bury MJ, Fehrenbacher L, Flynn PJ, Geyer CE Jr, Goel R, Jacobs SA, Johannes H, Julian TB, Mamounas EP, Provencher L, Rastogi P, Robidoux A, Stella PJ, Swain SM, Tan AR, Thirlwell MP, Wolmark N
|
|
|
49.
|
Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831. MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(33):3744-52, 2014 Nov 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Colon-Otero G, Davidson NE, Geyer CE Jr, Gralow J, Jeong JH, Mamounas E, Martino S, Perez EA, Rastogi P, Romond EH, Sledge G, Suman VJ, Swain SM, Winer EP, Wolmark N, Zujewski JA
|
|
|
50.
|
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial. MedStar authors:
Year: 2015
Citation: - Lancet Oncology. 16(9):1037-48, 2015 Sep.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Adams PT, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Liu Q, Mamounas EP, Margolese RG, Mehta RS, Paik S, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA
|
|
|
51.
|
Improving Documentation of Pain Management at MedStar Washington Cancer Institute. MedStar authors:
- Agrawal, Sundeep
- Beasley, Janet
- Chokshi, Puja
- Harkness, Jaylon
- Heller, Stephanie
- Jang, Sekwon
- Ranpura, Vishal
- Self, Linda
- Swain, Sandra M
- Wood, Lynne
- Yerasi, Charan
Year: 2015
Citation: - Journal of oncology practice/American Society of Clinical Oncology. 11(2):155-7, 2015 Mar.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Agrawal S, Beasley J, Chokshi P, Harkness J, Heller S, Jang S, Ranpura V, Self L, Swain SM, Wood L, Yerasi C
|
|
|
52.
|
|
|
|
53.
|
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl. MedStar authors:
Year: 2016
Citation: - Breast Cancer Research & Treatment. 155(2):235-51, 2016 Jan.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Amiri-Kordestani L, Chavez KJ, Conway CM, Dine JL, Greer YE, Hewitt SM, Lipkowitz S, Merchant AS, O'Sullivan CC, Sinclair S, Steinberg SM, Stone B, Swain SM, Voeller D
|
|
|
54.
|
Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Herbolsheimer, Pia M
- Lynce, Filipa
- Mete, Mihriye
- Nunes, Raquel
- Shara, Nawar M
- Swain, Sandra M
- Wray, Lynette
Year: 2016
Citation: - Breast Cancer Research & Treatment. 155(2):285-93, 2016 Jan.
Institution:
- MedStar Health Research Institute
- MedStar Health Research Institute
- MedStar Health Research Institute
- MedStar Washington Hospital Center
- MedStar Washington Hospital Center
- Washington Cancer Institute
- Washington Cancer Institute
- Washington Cancer Institute A
- Washington Cancer Instituteia
Department:
- MedStar Heart Institute
- MedStar Heart Institute
Medline publication type:
All authors: - Asch FM, Barac A, Herbolsheimer P, Isaacs C, Lynce F, Mete M, Nardacci MP, Nunes RA, Peshkin BN, Shara NM, Smith KL, Swain SM, Warren R, Wray L
|
|
|
55.
|
Body Mass Index at Diagnosis and Breast Cancer Survival Prognosis in Clinical Trial Populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38. MedStar authors:
Year: 2016
Citation: - Cancer Epidemiology, Biomarkers & Prevention. 25(1):51-9, 2016 Jan.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Anderson SJ, Cecchini RS, Costantino JP, Geyer CE Jr, Jeong JH, Lembersky BC, Paterson AH, Rastogi P, Romond EH, Swain SM, Tang G, Wolmark N
|
|
|
56.
|
|
|
|
57.
|
Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial. MedStar authors:
Year: 2017
Citation: - JAMA Oncology. 3(3):335-341, 2017 Mar 01
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Bandos H, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Johnson NL, Kim SR, Lipchik C, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N
|
|
|
58.
|
|
|
|
59.
|
Focus on You: Cancer clinical trials perspectives. MedStar authors:
- Newman, Antoinette F
- Robinson, Brandi N
- Swain, Sandra M
Year: 2016
Citation: - Contemporary Clinical Trials Communications. 4:170-178, 2016 Dec 15
Institution:
- MedStar Health Research Institute
- Washington Cancer Institute
Medline publication type:
All authors: - Newman AF, Robinson BN, Swain SM, Wallington SF
|
|
|
60.
|
Locoregional recurrence (LRR) after neoadjuvant chemotherapy (NAC): Pooled-analysis results from the Collaborative Trials in Neoadjuvant Breast Cancer (CTNeoBC). MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(26_suppl):61, 2014 Sep 10
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Bogaerts J, Bonnefoi HR, Cameron DA, Cortazar P, Costantino JP, Eidtmann H, Gerber B, Geyer CE, Gianni L, Loibl S, Mehta K, Rastogi P, Sridhara R, Swain SM, Untch M, Valagussa P, Von Minckwitz G, Wolmark N, Zhang L
|
|
|
61.
|
|
|
|
62.
|
Evaluation of lapatinib as a component of neoadjuvant therapy for HER2+ operable breast cancer: NSABP protocol B-41. MedStar authors:
Year: 2012
Citation: - Journal of Clinical Oncology. 30(18_suppl):LBA506, 2012 Jun 20
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Atkins JN, Azar CA, Baez-Diaz L, Bandos H, Bear HD, Brufsky A, Costantino JP, Farrar WB, Fehrenbacher L, Geyer CE, Kuebler JP, Mamounas EP, Margolese RG, Paik S, Rastogi P, Shibata HR, Swain SM, Tang G, Wolmark N
|
|
|
63.
|
|
|
|
64.
|
|
|
|
65.
|
|
|
|
66.
|
|
|
|
67.
|
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5. MedStar authors:
Year: 2017
Citation: - Clinical Breast Cancer. 17(1):48-54.e3, 2017 Feb
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Ansari B, Buyse ME, Conlin AK, Geyer CE Jr, Gross HM, Jacobs SA, Keogh GP, Lord RS, Mamounas EP, Mauquoi C, Patocskai EJ, Polikoff JA, Rastogi P, Robidoux A, Smith JW 2nd, Stella PJ, Swain SM, Wolmark N
|
|
|
68.
|
Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30. MedStar authors:
- McCarron, Edward C
- Swain, Sandra M
Year: 2018
Citation: - Journal of the National Cancer Institute. 110(2), 2018 Feb 01
Institution:
- MedStar Franklin Square Medical Center
- Washington Cancer Institute
Medline publication type:
All authors: - Bandos H, Brufsky AM, Fehrenbacher L, Ganz PA, Julian TB, Margolese RG, McCarron EC, Melnikow J, Rivera DR, Sturtz K, Swain SM, Wade JL 3rd
|
|
|
69.
|
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2. MedStar authors:
- Swain, Sandra M
- Zapas, John L
Year: 2017
Citation: - Journal of Clinical Oncology. 35(35):3942-3948, 2017 Dec 10
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Atkins JN, Biggs DD, Brufsky AM, Cecchini RS, Fehrenbacher L, Flynn PJ, Ganz PA, Geyer CE Jr, Gross HM, Jeong JH, Mamounas EP, Polikoff J, Rastogi P, Romond EH, Seay TE, Swain SM, Wade JL 3rd, Wahl TA, Wolmark N, Zapas JL
|
|
|
70.
|
SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Lynce, Filipa
- Swain, Sandra M
Year: 2017
Citation: - Oncologist. 22(5):518-525, 2017 May
Institution:
- MedStar Heart & Vascular Institute
- Washington Cancer Institute
Medline publication type:
All authors: - Asch FM, Barac A, Dang C, Isaacs C, Lynce F, Smith KL, Swain SM, Tan MT
|
|
|
71.
|
The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40. MedStar authors:
Year: 2016
Citation: - Annals of Surgical Oncology. 24(7):1853-1860, 2017 Jul
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Adams PT, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Kidwell KM, Mamounas EP, Margolese RG, Mehta RS, Paik S, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA, Zoon CK
|
|
|
72.
|
Pharmacogenetics in Practice: Estimating the Clinical Actionability of Pharmacogenetic Testing in Perioperative and Ambulatory Settings. MedStar authors:
- Brown, Ryan P
- Eldadah, Zayd A
- Hwang, Elizabeth
- Kmiecik, Susanna
- Levin, Bonnie
- Lundergan, Conor
- McAlduff, Joel
- Shapiro, Richard
- Smith, D Max
- Swain, Sandra M
Year: 2020
Citation: - Clinical and translational science. 13(3):618-627, 2020 05.
Institution:
- MedStar Health
- MedStar Heart & Vascular Institute
- MedStar Union Memorial Hospital
- MedStar Washington Hospital Center
- SiTEL
Department:
- Anesthesiology
- Associate Dean for Research Development
- Chief Medical Information Officer
- Pharmacogenomics
Medline publication type:
All authors: - Brown RP, Eldadah Z, Hwang E, Kmiecik S, Levin B, Lundergan C, McAlduff J, Peshkin BN, Shapiro R, Smith DM, Springfield TB, Swain SM
|
|
|
73.
|
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study. MedStar authors:
Year: 2020
Citation: - Lancet Oncology. 21(4):519-530, 2020 Apr.
Department: - Associate Dean for Research Development
Medline publication type:
All authors: - Benyunes MC, Ciruelos E, Clark E, CLEOPATRA study group, Cortes J, Im SA, Im YH, Kim SB, Knott A, Loi S, Miles D, Monturus E, Restuccia E, Schneeweiss A, Semiglazov V, Swain SM
|
|
|
74.
|
Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway. MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Year: 2020
Citation: - Breast Cancer Research & Treatment. 184(2):265-275, 2020 Nov.
Institution: - Washington Cancer Institute
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Elliott A, Heeke AL, Isaacs C, Korn WM, Lynce F, Pohlmann PR, Schwartzberg LS, Swain SM, Tan AR, Vidal G, Xiu J
|
|
|
75.
|
Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing. MedStar authors:
- Brandt, Nicole
- Brown, Ryan P
- Levin, Bonnie
- Smith, D Max
- Swain, Sandra M
- Walsh, Richard J
- Welsh, James C
Year: 2020
Citation: - Pharmacogenomics. 21(15):1085-1094, 2020 10.
Department:
- Assistant Vice President
- Associate Dean for Research Development
- MedStar Center for Successful Aging
- MedStar Health
- Pharmacogenomics
- Vice President
Medline publication type:
All authors: - Brandt N, Brown RP, Levin B, Namvar T, Peshkin BN, Smith DM, Springfield TB, Swain SM, Walsh RJ, Welsh JC
|
|
|
76.
|
Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer. MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Year: 2020
Citation: - Frontiers in Oncology. 10:1475, 2020.
Institution: - Washington Cancer Institute
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Elliott A, Gatalica Z, Heeke AL, Isaacs C, Khoury K, Korn WM, Lynce F, Pohlmann PR, Schwartzberg LS, Simon M, Swain SM, Tan AR, Xiu J
|
|
|
77.
|
UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. [Review] MedStar authors:
Year: 2021
Citation: - Cancers. 13(7), 2021 Mar 29.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Bottiglieri S, Carballido E, Cueto AD, Hicks JK, Imanirad I, Levine R, Nelson RS, Parker AS, Seligson ND, Swain SM, Tillman EM
|
|
|
78.
|
Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer. MedStar authors:
Year: 2021
Citation: - Cancers. 13(9), 2021 May 08.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Aapro M, Abdel Aziz H, Abdel Karim K, Abulkhair O, Al-Sukhun S, Anderson BO, Aref AT, Arun B, Azim HA, Bahie Eldin N, Bakkach J, Balch CM, Conte P, El Saghir NS, El-Shinawi M, El-Zawahry HM, Elghazaly H, Elghazawy H, ElMahdy M, Foheidi M, Frolova M, Ghosn M, Giuliano AE, Gligorov J, Guarneri V, Gulluoglu BM, Kandil A, Leung JWT, Orecchia R, Paltuev RM, Penault-Llorca F, Perez EA, Poortmans P, Rugo HS, Sabry M, Shehata MA, Swain SM, Yang W, Yip CH
|
|
|
79.
|
Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx R Digital Spatial Profiler. MedStar authors:
- Schlam, Ilana
- Swain, Sandra M
Year: 2021
Citation: - Cancers. 13(17), 2021 Sep 04.
Institution: - MedStar Washington Hospital Center
Department:
- Associate Dean for Research Development
- Hematology and Oncology
- MedStar Health
Medline publication type:
All authors: - Bergholtz H, Carter JM, Cesano A, Cheang MCU, Church SE, Divakar P, Fuhrman CA, Goel S, Gong J, Guerriero JL, Hoang ML, Hwang ES, Kuasne H, Lee J, Liang Y, Mittendorf EA, On Behalf Of The GeoMx Breast Cancer Consortium, Perez J, Prat A, Pusztai L, Reeves JW, Riazalhosseini Y, Richer JK, Sahin O, Sato H, Schlam I, Sorlie T, Stover DG, Swain SM, Swarbrick A, Thompson EA, Tolaney SM, Warren SE
|
|
|
80.
|
Nivolumab or capecitabine or combination therapy as adjuvant therapy for triple negative breast cancer (TNBC) with residual disease following neoadjuvant chemotherapy: the OXEL study. MedStar authors:
- Dilawari, Asma
- Gallagher, Christopher
- Khoury, Katia
- Lynce, Filipa
- Swain, Sandra M
Year: 2018
Department: - MedStar Georgetown University Hospital Residents
All authors: - Khoury K, Isaacs C, Gatti-Mays M, Donahue R, Schlom J, Wang H, Gallagher C, Graham D, Warren R, Dilawari A, Swain S, Pohlmann P, Lynce F.
|
|
|
81.
|
Clinical pharmacogenetics at MedStar Health: A pilot. MedStar authors:
- Eldadah, Zayd A
- Levin, Bonnie
- Lundergan, Conor F
- McAlduff, Joel
- Shapiro, Richard
- Smith, DM
- Swain, Sandra M
Year: 2019
All authors: - Smith DM, Peshkin BN, Springfield TB, Kmiecik SO, Shapiro R, Eldadah Z, Lundergan CF, McAlduff J, Levin B, Swain SM.
|
|
|
82.
|
Clinical pharmacogenetics pilot at MedStar Health: A surgical perspective. MedStar authors:
- Levin, Bonnie
- McAlduff, Joel
- Shapiro, Richard
- Smith, DM
- Swain, Sandra M
Year: 2019
All authors: - Smith DM, Peshkin BN, Springfield TB, Kmiecik SO, Shapiro R, McAlduff J, Levin B, Swain SM.
|
|
|
83.
|
|
|
|
84.
|
|
|
|
85.
|
|
|
|
86.
|
|
|
|
87.
|
|
|
|
88.
|
|
|
|
89.
|
|
|
|
90.
|
|
|
|
91.
|
|
|
|
92.
|
|
|
|
93.
|
|
|
|
94.
|
|
|
|
95.
|
|
|
|
96.
|
|
|
|
97.
|
|
|
|
98.
|
|
|
|
99.
|
|
|
|
100.
|
|
